[go: up one dir, main page]

WO2009108364A3 - Antagonistic analogues of ghrh - Google Patents

Antagonistic analogues of ghrh Download PDF

Info

Publication number
WO2009108364A3
WO2009108364A3 PCT/US2009/001279 US2009001279W WO2009108364A3 WO 2009108364 A3 WO2009108364 A3 WO 2009108364A3 US 2009001279 W US2009001279 W US 2009001279W WO 2009108364 A3 WO2009108364 A3 WO 2009108364A3
Authority
WO
WIPO (PCT)
Prior art keywords
analogues
hghrh
inhibit
ghrh
antagonistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/001279
Other languages
French (fr)
Other versions
WO2009108364A2 (en
Inventor
Zheng Xin Dong
Daniel B. Deoliveira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Ipsen Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma SAS filed Critical Ipsen Pharma SAS
Publication of WO2009108364A2 publication Critical patent/WO2009108364A2/en
Publication of WO2009108364A3 publication Critical patent/WO2009108364A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

There is provided a novel series of synthetic antagonistic analogues of hGHRH(l- 29)NH2 (SEQ E) NO: 1). These analogues inhibit the activity of endogenous hGHRH on the pituitary GHRH receptors, and therefore prevent the release of growth hormone. The analogues also inhibit the proliferation of human cancers through a direct effect on the cancer cells. The inhibitory potencies of the new analogues result from replacement of various amino acids.
PCT/US2009/001279 2008-02-27 2009-02-27 Antagonistic analogues of ghrh Ceased WO2009108364A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6731808P 2008-02-27 2008-02-27
US61/067,318 2008-02-27
US20736609P 2009-02-11 2009-02-11
US61/207,366 2009-02-11

Publications (2)

Publication Number Publication Date
WO2009108364A2 WO2009108364A2 (en) 2009-09-03
WO2009108364A3 true WO2009108364A3 (en) 2010-01-07

Family

ID=41016657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/001279 Ceased WO2009108364A2 (en) 2008-02-27 2009-02-27 Antagonistic analogues of ghrh

Country Status (1)

Country Link
WO (1) WO2009108364A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113929761B (en) * 2020-03-18 2024-02-20 深圳纳福生物医药有限公司 Modification and dimerization preparation of new growth hormone-releasing hormone-like peptides and their applications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US20050148515A1 (en) * 2002-08-09 2005-07-07 Dong Zheng X. Growth hormone releasing peptides
US20070042950A1 (en) * 2003-08-05 2007-02-22 Administrators Of The Tulane Educational Fund, The Antagonistic analogs of gh rh (2003)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US20050148515A1 (en) * 2002-08-09 2005-07-07 Dong Zheng X. Growth hormone releasing peptides
US20070042950A1 (en) * 2003-08-05 2007-02-22 Administrators Of The Tulane Educational Fund, The Antagonistic analogs of gh rh (2003)

Also Published As

Publication number Publication date
WO2009108364A2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
WO2005016953A3 (en) Antagonistic analogs of gh-rh (2003)
WO2006005140A3 (en) Proteinaceous compounds and uses therefor
WO2006099449A3 (en) Segmented endoprosthesis
PL375882A1 (en) Heterocyclic aromatic compounds useful as growth hormone secretagogues
WO2007056362A3 (en) Glucagon analogs exhibiting physiological solubility and stability
GT201200236A (en) AGONIST POLYPEPTIDES THAT LINK TO DR5
GB0713652D0 (en) Formulations of human growth hormone comprising a non-naturally encoded amino acid
EP1799208A4 (en) Heterocyclic aromatic compounds useful as growth hormone secretagogues
IL200312A0 (en) Template-fixed peptidomimetics
WO2009120831A3 (en) Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh
MX2009008561A (en) Method of treating cell proliferative disorders using growth hormone secretagogues.
WO2006113452A3 (en) Glycoprotein hormone analogs
WO2009108364A3 (en) Antagonistic analogues of ghrh
NZ592670A (en) Corticotrophin releasing hormone receptor 2 peptide agonists and uses thereof
MXPA05013465A (en) Cis-imidazolines as mdm2 inhibitors.
EP3983002A4 (en) Therapeutic pegylated growth hormone antagonists
WO2003087069A3 (en) Dipeptidic growth hormone secretagogues
PH12013502021A1 (en) Platelet aggregation inhibitor composition
WO2007008937A8 (en) Adiponectin variants
EP2129359A4 (en) Chimeric peptide antagonist for gpcr135 or gpcr142
EP1714976A4 (en) Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage
WO2010133806A3 (en) Marked peptides and use thereof for assaying circulating irap
WO2007033211A3 (en) Regulation of brain natriuretic peptide and catecholamines for the treatment of cardiovascular diseases
WO2005105832A3 (en) Biologically active peptide vapeehptllteaplnpk derivatives
WO2007139820A3 (en) Inhibition of skp2-cyclin a interaction

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09714255

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09714255

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE